Lindsey Jay is a postbaccalaureate IRTA in the lab of George Kunos, M.D., Ph.D., at the NIH’s National Institute of Alcohol Abuse and Alcoholism (NIAAA). She graduated in June 2018 from the University of Chicago with degrees in Neuroscience and Biology. In Dr. Kunos’ lab, Lindsey assists with studies of a novel drug developed in the lab for the treatment of lung and skin fibrosis, a thickening and scarring of connective tissue that can occur spontaneously or due to injury. She hopes to pursue a career in pharmaceutical and drug development in the future. In her free time, Lindsey enjoys baking and painting.
Lucy Bauer is a postbacc Intramural Research Training Awardee at the National Center for Complementary and Integrative Health (NCCIH). When she is not toiling away in the lab, Lucy enjoys exploring the outdoors and entertaining her cat’s delusions of grandeur.
Lucy Kotlyanskaya is a graduate student researcher at the National Institute of Neurological Disorders and Stroke (NINDS), where she conducts research on the molecular mechanisms of axon guidance, neuronal cell motility and morphogenesis using the model organism Drosophila melanogaster.
Michael M. Gottesman, M.D., is the Chief of the Laboratory of Cell Biology at the Center for Cancer Research of the National Cancer Institute. Dr. Gottesman and colleagues pioneered the characterization of molecular mechanisms that result in failure to cure cancer with chemotherapy. He also served as the NIH Deputy Director for Intramural Research from 1994-2022.
Mohor Sengupta, Ph.D., is an IRP postdoctoral fellow with NIH’s National Eye Institute. Mohor received her Ph.D. from the Saha Institute of Nuclear Physics in India. She studied pathological markers in traumatic spinal cord injury during her graduate studies. At the IRP, Mohor is studying retinal degeneration and repair after injury. Outside the lab, she enjoys reading, watching movies, and hiking with her husband.
Noah, 22, of Lusby, Maryland, is a poet and writer, and has been an NIH study participant since she was 2 years old, when she was diagnosed with a rare metabolic disorder called abetalipoproteinemia (ABL). In addition to participating in an IRP study of metabolic disorders like ABL, Noah also has been part of the NIH’s Undiagnosed Diseases Program for several years, since many of the symptoms that make daily life difficult for her cannot be explained by her ABL diagnosis. Noah credits William Shakespeare with instilling a love of literature in her. When she’s not reading world literature, she’s writing plays and short stories as well as poetry that her mom, an artist, illustrates. You can learn more about Noah’s story by visiting the website of The Children’s Inn at NIH, where she stays free of charge when she is receiving treatment or undergoing tests at the NIH.
Richard Leapman, Ph.D., is the Scientific Director at NIH's National Institute of Biomedical Imaging and Bioengineering (NIBIB), as well as Chief of NIBIB’s Laboratory of Cellular Imaging and Macromolecular Biophysics. His research focuses on the development of new methods based on electron microscopy and related techniques, with the ultimate aim to expand knowledge about complex biological and disease processes, as well as to characterize morphologically the action of diagnostic markers and therapeutic agents in cells. His group has been particularly active in developing the techniques of electron energy loss spectroscopy (EELS) and combining it with scanning transmission electron microscopy (STEM) to provide an unprecedented high spatial resolution for nanoanalysis of biological structures.
Robin Arnette, Ph.D., is a science writer and editor at the National Institute of Environmental Health Sciences (NIEHS) in Research Triangle Park, North Carolina. As a member of the NIEHS Office of Communications and Public Liaison, Arnette shares stories about NIEHS research by developing press releases, producing science videos, and contributing to the Environmental Factor, the NIEHS newsletter.
